The reliability of reports of recent psychoactive substance use at the time of admission to an acute mental health unit

Journal of Dual Diagnosis

Volumn 5, Issue 3-4, 2009, Pages 392-403

  Chung, Rhoderic K ^a   Large, Matthew M ^b   Starmer, Graham A ^c   Tattam, Bruce N ^c   Paton, Michael B ^d   Nielssen, Olav B ^b  

^a Private Practice   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d New South Wales Government   (Australia)

Author keywords

Cannabis; Mass spectrometry; Mental disorder; Psychosis; Reliability; Schizophrenia; Stimulants; Substance abuse

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; CAFFEINE; CANNABIS; CARBAMAZEPINE; COCAINE; NEUROLEPTIC AGENT; NICOTINE; OPIATE; PSYCHOTROPIC AGENT;

ACCURACY; ADJUSTMENT DISORDER; ADULT; ALCOHOLISM; ARTICLE; BIPOLAR DISORDER; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERVIEW; MAJOR DEPRESSION; MALE; MASS FRAGMENTOGRAPHY; MENTAL HEALTH CENTER; PSYCHOSIS; QUESTIONNAIRE; RELIABILITY; SCHIZOPHRENIA; SELF REPORT; SUBSTANCE ABUSE;

EID: 77951430786     PISSN: 15504263     EISSN: 15504271     Source Type: Journal    
DOI: 10.1080/15504260903176039     Document Type: Article

References (24)

1. American Psychiatric Association DSM-III-R. (1997). Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
2. Appleby, L., Luchins, D. J., & Dyson, V. (1995). Effects of mandatory drug screens on substance use diagnoses in a mental hospital population. Journal of Nervous and Mental Disease, 183, 183-184.
3. Barnaby, B., Drummond, C., McCloud, A., Burns, T., & Omu, N. (2003). Substance misuse in psychiatric inpatients: comparison of a screening questionnaire survey with case notes. British Medical Journal, 327, 783-1734
4. Barral, M. V., & Standage, K. (1992). An audit of substance use disorders on a general hospital psychiatric unit. Canadian Journal of Psychiatry, 37, 130-132.
5. Brown, J., Kranzler, H. R., & Del Boca, F. K. (1992). Self-reports by alcohol and drug abuse inpatients: Factors affecting reliability and validity. British Journal of Addiction, 87, 1013-1024.
6. Chen, C., Balogh, M., Bathija, J., Howanitz, E., Plutchik, R., & Conte, H. R. (1992). Substance abuse among psychiatric inpatients. Comprehensive Psychiatry, 33, 60-64.
7. Del Boca, F. K., & Darkes, J. (2003). The validity of self-reports of alcohol consumption: State of the science and challenges for research. Addiction, 98(2), S1-S12.
8. Del Boca, F. K., & Noll, J. A. (2000). Truth or consequences: The validity of selfreport data in health services research on addictions. Addiction, 95(3), S347-S360.
9. Galletly, C. A., Field, C. D., & Prior, M. (1993). Urine drug screening of patients admitted to a state psychiatric hospital. Hospital and Community Psychiatry, 44, 587-589.
10. Gold, M. S., & Dackis, C. A. (1986). Role of the laboratory in the evaluation of suspected drug abuse. Journal of Clinical Psychiatry, 47(1), S17-S23.
11. Hall, R. C., Popkin, M. K., Devaul, R., & Stickney, S. K. (1977). The effect of unrecognized drug abuse on diagnosis and therapeutic outcome. American Journal of Drug Alcohol Abuse, 4, 455-465.
12. Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33, 159-174.
13. Mallin, R., Slott, K., Tumblin, M., & Hunter, M. (2002). Detection of substance use disorders in patients presenting with depression. Substance Abuse, 23, 115-120.
14. Mauri, M. C., Volonteri, L. S., De Gaspari, I. F., Colasanti, A., Brambilla, M. A., & Cerruti, L. (2006). Substance abuse in first-episode schizophrenic patients: A retrospective study. Clinical Practice and Epidemiology in Mental Health, 2, 4.
15. Nieuwstraten, C., Labiris, N. R., & Holbrook, A. (2006). Systematic overview of drug interactions with antidepressant medications. Canadian Journal of Psychiatry, 51, 300-316.
16. Perkins, D. O., Gu, H., Weiden, P. J., McEvoy, J. P., Hamer, R. M., Lieberman, J. A., & Comparison of Atypicals in First Episode Study Group. (2008). Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: A randomized, double-blind, flexible-dose, multicenter study. Journal of Clinical Psychiatry, 69, 106-113.
17. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., et al. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. The Journal of the American Medical Association, 264, 2511-2518.
18. Selten, J. P., Bosman, I. J., de Boer, D., Veen, N. D., Van Der Graaf, Y., Maes, R. A., et al. (2002). Hair analysis for cannabinoids and amphetamines in a psychosis incidence study. European Neuropsychopharmacology, 12(1), 27-30.
19. Spitzer, R. L., Williams, J. B., Gibbon, M., & First, M. B. (1992). The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Archives of General Psychiatry, 49, 624-629.
20. SPSS for Windows, Rel. 15.0 (2006). Chicago: SPSS Inc.
21. Starmer, G. A., Cairns, D., Mascord, D. J., Perl, J., Tattam, B., Vine, J. H., et al. (1992). Effects of psychoactive drugs on car driving performance: Drugs in crash-involved drivers. Clinical Neuropharmacology, 15(1), S598A- S600A.
22. Swanson, J. W., Van Dorn, R. A., Swartz, M. S., Smith, A., Elbogen, E. B., & Monahan, J. (2008). Alternative pathways to violence in persons with schizophrenia: The role of childhood antisocial behavior problems. Law and Human Behavior, 32, 228-240.
23. Swartz, M. S.,Wagner, H. R., Swanson, J. W., Stroup, T. S., McEvoy, J. P., Canive, J. M., et al. (2006). Substance use in persons with schizophrenia: Baseline prevalence and correlates from the NIMH CATIE study. Journal of Nervous and Mental Disease, 194, 164-172.
24. Swartz, M. S., Swanson, J. W., & Hannon, M. J. (2003). Detection of illicit substance use among persons with schizophrenia by radioimmunoassay of hair. Psychiatric Services, 54, 891-895.